BARCLAYS PLC - SATSUMA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$11
-21.4%
15,841
-0.3%
0.00%
Q4 2022$14
-100.0%
15,893
-92.7%
0.00%
-100.0%
Q3 2022$1,314,000
+56.8%
218,902
+8.1%
0.00%0.0%
Q2 2022$838,000
+9.0%
202,4780.0%0.00%0.0%
Q1 2022$769,000202,4780.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 20,711$81,0000.89%
RA Capital Management 4,681,858$18,212,0000.33%
Ghost Tree Capital, LLC 200,000$778,0000.22%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$7,336,0000.13%
Virtu Financial LLC 39,062$152,0000.03%
Quantitative Systematic Strategies LLC 14,195$55,0000.01%
Cetera Advisor Networks LLC 85,000$331,0000.01%
BAILARD, INC. 38,600$150,0000.01%
Chicago Partners Investment Group LLC 14,081$52,0000.01%
EXANE DERIVATIVES 4,078$15,863,0000.01%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders